Shiqiang Hou

434 total citations
26 papers, 258 citations indexed

About

Shiqiang Hou is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shiqiang Hou has authored 26 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shiqiang Hou's work include Glioma Diagnosis and Treatment (6 papers), Cancer-related molecular mechanisms research (6 papers) and MicroRNA in disease regulation (5 papers). Shiqiang Hou is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Cancer-related molecular mechanisms research (6 papers) and MicroRNA in disease regulation (5 papers). Shiqiang Hou collaborates with scholars based in China, Hong Kong and United States. Shiqiang Hou's co-authors include Ning Lin, Yinan Chen, Chunjing Jin, Jinlong Shi, Chuandong Cheng, Rui Jiang, Guowang Xu, Xingxing Gu, Hao Zuo and Song He and has published in prestigious journals such as Oncogene, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Shiqiang Hou

24 papers receiving 256 citations

Peers

Shiqiang Hou
Changqing Pan China
Chuanhong Zhong China
Alafate Wahafu China
Madison Butler United States
Y Suh South Korea
Omanma Adighibe United Kingdom
Rujia Mi China
Changqing Pan China
Shiqiang Hou
Citations per year, relative to Shiqiang Hou Shiqiang Hou (= 1×) peers Changqing Pan

Countries citing papers authored by Shiqiang Hou

Since Specialization
Citations

This map shows the geographic impact of Shiqiang Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiqiang Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiqiang Hou more than expected).

Fields of papers citing papers by Shiqiang Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiqiang Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiqiang Hou. The network helps show where Shiqiang Hou may publish in the future.

Co-authorship network of co-authors of Shiqiang Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Shiqiang Hou. A scholar is included among the top collaborators of Shiqiang Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiqiang Hou. Shiqiang Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Chao, Shiqiang Hou, Ziying Wu, et al.. (2025). Self-Assembling Nanoparticles Orchestrate Cuproptosis-Immunotherapy Synergy to Suppress Postoperative Glioma Recurrence. ACS Applied Materials & Interfaces. 17(47). 64322–64339.
2.
Wang, Shuai, Chao Wang, Chao Zhang, et al.. (2025). The JAK1/STAT3 pathway mediates the effects of SERPINH1 on glioma EMT. International Immunopharmacology. 157. 114731–114731. 2 indexed citations
3.
Wang, Yu, Shuai Wang, Yuhao Wang, et al.. (2024). Glucose regulates the HMGB1 signaling pathway through SIRT1 in glioma. Cellular Signalling. 118. 111137–111137. 2 indexed citations
4.
Zhang, Chao, Kang Zhang, Chengcheng Wang, et al.. (2024). Identification of a nomogram predicting overall survival based on ADAP2-related apoptosis genes in gliomas. International Immunopharmacology. 142(Pt A). 113084–113084. 2 indexed citations
5.
Shi, Xingjie, et al.. (2024). A mendelian randomization study investigates the causal relationship between immune cell phenotypes and cerebral aneurysm. Frontiers in Genetics. 15. 1333855–1333855. 6 indexed citations
6.
Zhang, Chao, Peng Qian, Chengcheng Wang, et al.. (2024). Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/STAT3 pathway. Journal of Cancer Research and Clinical Oncology. 150(3). 168–168. 23 indexed citations
7.
Hou, Shiqiang, Ning Lin, & Yi Wang. (2024). Preparation of Red-Emitting CDs for Glioma Imaging and Fe3+ Sensing. ACS Omega. 9(44). 44418–44424. 2 indexed citations
8.
Wang, Yu, Yuhao Wang, Shuai Wang, et al.. (2024). Comprehensive analysis of CYBB as a prognostic marker and therapeutic target in glioma: A bioinformatics approach. Heliyon. 10(8). e29549–e29549. 3 indexed citations
9.
Jin, Chunjing, et al.. (2024). Integrative analysis indicates the potential values of ANKRD53 in stomach adenocarcinoma. Discover Oncology. 15(1). 188–188. 1 indexed citations
10.
Wang, Jiajun, Kang Zhang, Yuhao Wang, et al.. (2024). LFHP-1c improves cognitive function after TBI in mice by reducing oxidative stress through the PGAM5-NRF2-KEAP1 ternary complex. Heliyon. 10(17). e36820–e36820. 1 indexed citations
11.
Dong, Yu, Wei Shao, Dongrui Zhou, et al.. (2023). Interactions between microglia and glioma in tumor microenvironment. Frontiers in Oncology. 13. 1236268–1236268. 8 indexed citations
12.
Chen, Yinan, et al.. (2023). GTF2E2 downregulated by miR-340-5p inhibits the malignant progression of glioblastoma. Cancer Gene Therapy. 30(12). 1702–1714. 4 indexed citations
13.
Zhang, Chao, Yu Wang, Wei Shao, et al.. (2023). A novel NFAT1-IL6/JAK/STAT3 signaling pathway related nomogram predicts overall survival in gliomas. Scientific Reports. 13(1). 11401–11401. 7 indexed citations
14.
Hou, Shiqiang, et al.. (2022). Prognostic Value of Hematologic Prealbumin/Fibrinogen Ratio in Patients with Glioma. World Neurosurgery. 160. e442–e453. 2 indexed citations
15.
Hou, Shiqiang, Dandan Chen, Jie Liu, et al.. (2021). Profiling and Molecular Mechanism Analysis of Long Non-Coding RNAs and mRNAs in Pulmonary Arterial Hypertension Rat Models. Frontiers in Pharmacology. 12. 709816–709816. 11 indexed citations
16.
Sun, Junlong, Rui Jiang, Shiqiang Hou, et al.. (2020). Pathological Grade-Associated Transcriptome Profiling of lncRNAs and mRNAs in Gliomas. Frontiers in Oncology. 10. 253–253. 2 indexed citations
17.
Lin, Ning, Wentao Li, Xiefeng Wang, et al.. (2020). <p>Upregulation of miR-340 Inhibits Tumor Growth and Mesenchymal Transition via Targeting c-MET in Glioblastoma</p>. Cancer Management and Research. Volume 12. 3343–3352. 4 indexed citations
18.
Jin, Chunjing, et al.. (2018). Preoperative Hematologic Inflammatory Markers as Prognostic Factors in Patients with Glioma. World Neurosurgery. 119. e710–e716. 39 indexed citations
19.
Jiang, Rui, et al.. (2017). Up-regulation of FOS-like antigen 1 contributes to neuronal apoptosis in the cortex of rat following traumatic brain injury. Metabolic Brain Disease. 33(1). 115–125. 6 indexed citations
20.
Wan, Chunhua, Shiqiang Hou, Runzhou Ni, et al.. (2013). MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability. Oncogene. 34(2). 237–245. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Changqing Pan Breakdown of academic impact, for papers by Chuanhong Zhong Breakdown of academic impact, for papers by Alafate Wahafu Breakdown of academic impact, for papers by Madison Butler Breakdown of academic impact, for papers by Y Suh Breakdown of academic impact, for papers by Omanma Adighibe Breakdown of academic impact, for papers by Rujia Mi
Rankless by CCL
2026